Lysophosphatidylcholine induces platelet-derived growth factor gene expression in a human mesangial cell line  Yoshinori Tone, Susumu Yukawa, Zac Varghese,

Slides:



Advertisements
Similar presentations
Volume 68, Issue 2, Pages (August 2005)
Advertisements

Renal manifestations in Fabry disease and therapeutic options
Anemia management in chronic kidney disease
Lipopheresis in the nephrotic syndrome
162. Stability of Polymer/Plasmid DNA Complexes In Vitro and In Vivo
Human mesangial cells express inducible macrophage scavenger receptor
Volume 72, Issue 1, Pages (July 2007)
Dysregulation of LDL receptor under the influence of inflammatory cytokines: A new pathway for foam cell formation1  Dr Xiong Z. Ruan, Zac Varghese, Stephen.
Progression of renal failure and hypertensive nephrosclerosis
John P. Middleton, Patrick H. Pun  Kidney International 
M. Fukagawa, S. Nakanishi, J.J. Kazama  Kidney International 
Volume 56, Pages S202-S205 (July 1999)
Verotoxin biology: molecular events in vascular endothelial injury
Vitamin E treatment of experimental glomerular disease in rats
Volume 58, Issue 1, Pages (July 2000)
Volume 59, Issue 4, Pages (April 2001)
Volume 70, Pages S21-S25 (December 2006)
Lipid redistribution in renal dysfunction
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
Volume 53, Issue 5, Pages (May 1998)
Volume 61, Issue 5, Pages (May 2002)
The epidemiology of chronic kidney disease
The role of protein kinase C activation in diabetic nephropathy
Stefan Frank, Heiko Kämpfer, Christian Wetzler, Josef Pfeilschifter 
Volume 61, Issue 1, Pages S106-S109 (January 2002)
Volume 57, Issue 3, Pages (March 2000)
A physician's perseverance uncovers problems in a key nephrology study
The third World Kidney Day: Looking back and thinking forward
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 85, Issue 5, Pages (May 2014)
674. Molecular, Biochemical and Biomechanical Analysis of Articular Cartilage Repaired with Genetically Modified Chondrocytes Expressing Insulin-Like.
Volume 87, Issue 3, Pages (March 2015)
Methods for guideline development
AGEs in foods: Do they play a role in uremia?
Molecular Therapy  Volume 18, Pages S260-S261 (May 2010) DOI: /S (16)
Volume 56, Pages S137-S140 (July 1999)
Volume 56, Issue 4, Pages (October 1999)
Simvastatin in nephrotic syndrome
Nephrology Crossword: Glomerulonephritis
Lipoprotein-stimulated mesangial cell proliferation and gene expression are regulated by lipoprotein lipase1  Frazier T. Stevenson, Gregory C. Shearer,
Volume 71, Issue 4, Pages (February 2007)
Florian E. Togel, Christof Westenfelder 
A man with a hole in his penis
Fibroblast growth factor 23: the making of a hormone
The treatment of acute interstitial nephritis: More data at last
Organ transplantation goes to the movies
Volume 60, Issue 1, Pages (July 2001)
Atherosclerotic nephropathy
Volume 55, Pages S3-S16 (June 1999)
740. Prevention of Radiation-Induced Lung Injury by Administration of Gene-Modified Mesenchymal Stem Cells    Molecular Therapy  Volume 20, Pages S285-S286.
Volume 61, Issue 3, Pages (March 2002)
Takamune Takahashi, Uyen Huynh-Do, Thomas O. Daniel 
Molecular Therapy  Volume 21, Pages S247-S248 (May 2013)
Volume 54, Pages S159-S161 (September 1998)
Volume 56, Pages S167-S170 (July 1999)
Effect of lipid-lowering strategies on tubular cell biology
Charles A. Herzog  Kidney International 
Volume 56, Pages S254-S255 (July 1999)
Volume 70, Issue 3, Pages (August 2006)
Volume 56, Pages S171-S173 (July 1999)
Cultured human glomerular mesangial cells express the C5a receptor
Volume 75, Issue 6, Pages (March 2009)
William G. Couser, Jeffrey W. Pippin, Stuart J. Shankland 
Volume 80, Issue 9, Pages (November 2011)
Volume 55, Pages S41-S46 (June 1999)
Volume 68, Issue 2, Pages (August 2005)
Volume 55, Issue 4, Pages (April 1999)
Development and differentiation of endothelium
The Ebf1 knockout mouse and glomerular maturation
Presentation transcript:

Lysophosphatidylcholine induces platelet-derived growth factor gene expression in a human mesangial cell line  Yoshinori Tone, Susumu Yukawa, Zac Varghese, John F. Moorhead  Kidney International  Volume 56, Pages S182-S185 (July 1999) DOI: 10.1046/j.1523-1755.1999.07147.x Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 1 The potential of phosphatidylcholine (PC) and lysophosphatidylcholine (lysoPC) to induce [3H] thymidine incorporation. LysoPC treatment up-regulated the [3H] thymidine incorporation level in (A) a dose- and (B) time-dependent fashion in human glomerular mesangial cell line (HMCL). PC treatment did not increase [3H] thymidine incorporation (A, B). The control values were at 0 μ M of PC or lysoPC. Data express mean ± SE. Kidney International 1999 56, S182-S185DOI: (10.1046/j.1523-1755.1999.07147.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 2 The potential of phosphatidylcholine (PC) and lysophosphatidylcholine (lysoPC) to induce platelet-derived growth factor (PDGF) gene expression. PC treatment did not induce the mRNA expression of either PDGF A or B chains in human glomerular mesangial cell line (HMCL). LysoPC did not induce PDGF A chain mRNA expression but did induce B chain mRNA expression. The control values were at 0 μ M of PC or lysoPC. These data are representative of three replicate experiments. Kidney International 1999 56, S182-S185DOI: (10.1046/j.1523-1755.1999.07147.x) Copyright © 1999 International Society of Nephrology Terms and Conditions